This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
San Diego-based Arcturus Therapeutics , a developer of RNAi technology, said it has raised $5M in a Series A funding round. According to Arcturus, the funding came from multiple private capital,, high net worth investors from Canada, Japan, and the United States. Names of those capital sources were not announced.
San Diego-based Arcturus Therapeutics , a developer of mRNA-based treatments for disease, has signed a deal to receive up to $3M in funding from the Cystic Fibrosis Foundation Therapeutics, a nonprofit which supports drug discovery and development. READ MORE>>.
San Diego-based Arcturus Therapeutics has received up to $220M in additional financial commitments from the country of Singapore, after receiving positive Phase 1/2 study results on one of its compounds. READ MORE>>.
Monrovia, California-based Prolacta Bioscience , the venture backed firm developing human milk fortifiers for premature infants, announced this morning that it will be donating funds to the Susan G. The firm said it will commit a minimum amount of $25,000 annually to fund programs at Komen.
Los Angeles-based Arcturus, a developer of 3D video editing tools, said Wednesday afternoon that it has raised $11M in a Series A funding round. The funding was led by Cloudtree Ventures, and also included Autodesk and Epic Games. The startup is led by CEO Kamal Mistry.
Santa Monica-based Zag , which has developed an automobile configuration and buying service for affinity organizations like credit unions and automobile organizations, has a funding round of undisclosed size. Tags: automobile venture auto capital funding. The firm recently spun out True Car, an automotive pricing information site.
San Diego-based Arcturus Therapeutics said today Cystic Fibrosis Foundation Therapeutics has agreed to provide $3 million to fund research and development of a new messenger RNA drug that could be broadly used to treat cystic fibrosis patients. Arcturus says its technology can be used to make.
Prolacta is venture backed by such companies as Health Evolution Partners, Alta Partners, DFJ Frontier, Arcturus Capital, DFJ Mercury, Funk Ventures, Phillip Capital, Gideon Hixon Fund, and Draper Associates. The use of human milk helps avoid serious side effects that can occur with premature infants if they use cow-based milk.
Monrovia-based Ondax , a manufacturer of volume holographic grating filters and lasers, said Tuesday that it has officially closed its $2.2M, Series E funding round. The round was led by Prospector Equity Capital and Arcturus Capital, and also included the Pasadena Angels and Tech Coast Angels.
The firm said it has scored Series A funding from Zag, Anthem Venture Partners, Global Retail Partners, Capricorn, Capital One Auto Finance, ARcturus Capital, Scott Painter, and co-founder Tom Taira. According to TrueCar, it will provide information about new car pricing, using the actual price people have paid for cars.
in an equity funding round, according to a regulatory filing by the firm yesterday. Source of the funding was not disclosed. Dr. Schuh was previously CEO and Director of AviaraDx, and also served at Arcturus Bioscience and Sequenom. San Diego-based Sorrento Therapeutics , a new biotechnology startup, has raised $2.3M
in a funding round. Apparently, the company was a victim of TechCrunch's Arrington's crusade against PR embargoes, and disclosed the funding based on an embargoed draft. Zag is venture backed by Anthem Ventures, Arcturus Capital, Capital One, Capricorn Management, GRP Partners, and the Tech Coast Angels, along with USAA.
The board that fired Arcturus Therapeutics co-founder and CEO Joseph E. In a lawsuit filed Tuesday (see below) and in an open letter to shareholders issued Wednesday , the Arcturus (NASDAQ: ARCT ) board says a pattern of alleged misconduct, deceit, and failed leadership by Payne led to his termination on January 25. Payne, who.
in a Series A funding round. The round was led by Rincon Venture Partners, and also included Arcturus Capital and Momentum Venture Management. The firm's Series A funding will be used to add resources to build out the company's databases and to reinforce its operations.
Zag is venture backed by Anthem Venture Partners, USAA, GRP Partners, Arcturus Capital, Callaway Cars and the Skoll Fund. Zag's technology differs from other similar programs in that it offers fully detailed pricing on exact options, rather than just feeding leads into a dealership's fleet or online department. READ MORE>>.
The firm is backed by Anthem Venture Partners, Capital One Auto Finance, GRP Partners, Arcturus Capital, Callaway Cars and the Skoll Fund. Zag develops software used for configuring and pricing new and used automobiles, which it provides on a white-label basis to affinity buying programs. READ MORE>>
Zag is headed by former CarsDirect CEO Scott Painter, and is venture backed by Anthem Venture Partners, Capital One Auto Finance, GRP Partners, Arcturus Capital, Callaway Cars and the Skoll Fund. Zag has now signed up 14 AAA motor clubs, and also provides its technology to Capital One Auto Finance, Overstock.com, and other sites.
Biotech startups rolled in cash this week. By our count, investors put more than $800 million into life-sciences startups in four days. The money came from a wide range of backers, not just traditional biotech venture firms. It’s early yet in 2018, but the current count could put life-sciences companies on pace to bust past last year’s $17.6
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content